The availability of prophylactic human papillomavirus (HPV) vaccines has provided powerful
tools for primary prevention of cervical cancer and other HPV-associated diseases. Since …

Since 2006, 115 countries and territories have introduced human papillomavirus (HPV)
vaccination programs. Several efforts have been undertaken to evaluate the impact of HPV …

Human papillomavirus (HPV) is the most common sexually transmitted infection, with 15
HPV types related to cervical, anal, oropharyngeal, penile, vulvar, and vaginal cancers …

This article presents the World Health Organization's (WHO) recommendations on the use of
human papillomavirus (HPV) vaccines excerpted from the WHO position paper on Human …

Human papilloma virus (HPV) vaccination has been implemented in several countries for
about the past 7 years, mainly in the adolescent female population, with varying coverage …

Human papillomavirus (HPV) is the most common sexually transmitted infection in the
United States, and persistent HPV infection is strongly associated with risk of cervical cancer …

Prophylactic vaccines for human papillomavirus (HPV) are being introduced in many
countries for the prevention of cervical cancer, the second most important cause of cancer …

PROBLEM: Virtually all women who have cervical cancer are infected with the human
papillomavirus (HPV). Of the 275 000 women who die from cervical cancer every year, 88 …

Human papillomavirus (HPV) vaccines are available in the United States and around the
world to prevent HPV-associated diseases including cervical cancer and genital warts. HPV …

We currently have the knowledge and experience to prevent much of human papillomavirus
(HPV)-related disease burden globally. In many countries where prophylactic HPV …